
Minerva Neurosciences, Inc. — Investor Relations & Filings
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-27 | English | |
| 424B5 | 2026-05-27 | English | |
| 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | |
| DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47845662 | 8-K | 2026-05-27 | English | ||
| 47845919 | 424B5 | 2026-05-27 | English | ||
| 41373781 | 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 41366414 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 35695380 | ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 35694016 | DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 33644856 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-06 | English | ||
| 32997937 | EFFECT - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-03-20 | English | ||
| 30823528 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823514 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823505 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 30823508 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 30823520 | 8-K Filing | 2026-02-03 | English | ||
| 12747695 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 12747696 | 424B3 | 2026-01-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
Minerva Neurosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Minerva Neurosciences, Inc. (id: 35086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.